A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. (Record no. 21001363)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01940 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516045136.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201109s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1532-1827 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/bjc.2011.183 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | O'Day, S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20110916 |
245 00 - TITLE STATEMENT | |
Title | A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | British journal of cancer |
Date of publication, distribution, etc. | Jul 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 346-52 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dacarbazine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Integrin alphaV |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melanoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Uveitis |
General subdivision | chemically induced |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pavlick, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Loquai, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lawson, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gutzmer, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Richards, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schadendorf, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thompson, J A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gonzalez, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Trefzer, U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mohr, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ottensmeier, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chao, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhong, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Boer, C J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Uhlar, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marshall, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gore, M E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lang, Z |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hait, W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ho, P |
773 0# - HOST ITEM ENTRY | |
Title | British journal of cancer |
Related parts | vol. 105 |
-- | no. 3 |
-- | p. 346-52 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/bjc.2011.183">https://doi.org/10.1038/bjc.2011.183</a> |
Public note | Available from publisher's website |
No items available.